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Abstract: 
To assess the educational needs of North Carolina primary care physicians (PCPs) about direct-
to-consumer (DTC) genetic testing, surveys were mailed to 2,402 family and internal medicine 
providers in North Carolina. Out of 382 respondents, 323 (85%) felt unprepared to answer 
patient questions and 282 (74%) reported wanting to learn about DTC genetic testing. A total of 
148 (39%) were aware of DTC genetic testing. Among these, 63 (43%) thought DTC genetic 
testing was clinically useful. PCPs who felt either unprepared to answer patient questions 
(OR = 0.354, p = 0.01) or that DTC genetic testing was clinically useful (OR = 5.783, p = 0.00) 
were more likely to want to learn about DTC genetic testing. PCPs are interested in learning 
about DTC genetic testing, but are mostly unaware of DTC testing and feel unprepared to help 
patients with DTC testing results. Familiar and trusted channels that provide the information and 
tools PCPs need to help answer patient’s questions and manage their care should be used when 
creating educational programs. 
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Article: 
Introduction 
In 2007, companies began offering personal genome tests for the prediction of common complex 
diseases and medication responses, based on genome-wide association study (GWAS) variants, 
over the internet (Offit 2008). Some companies sell these tests directly to consumers without 
requiring consultation with a health care provider. On their websites these companies state that 
they are not offering medical advice, diagnosis or treatment, and they recommend that 
consumers consult with their primary care physicians (PCPs) to discuss the results of their test 
before making medical decisions (23andMe 2011; deCODEme 2011; Pathway Genomics 2011). 
PCPs are the front line of medical care, and see patients at risk for, and affected by, common 
complex diseases, such as heart disease and diabetes (Feero 2008). Many times, information 
about health decisions can be made over several visits, thereby forging a relationship over time. 
Patients tend to trust and value these relationships and seek out their PCPs opinions when 
making healthcare decisions. Because of this relationship, it’s been suggested that PCPs are the 
appropriate providers to see patients who are identified at increased risk for common complex 
genetic diseases based on their family history or genetic test results (Burke and Emery 2002; 
Guttmacher et al. 2001). 
Studies indicate that patients do seek out their PCPs to discuss their genetic test results and 
obtain the appropriate follow-up care (Burke 2004; Holtzman and Watson 1997; Miller et 
al. 2010; Morren et al. 2007) Additionally, there is evidence that patients are talking to their 
health care providers about personal genome testing (Kolor et al. 2009; Ohata et al. 2009; Powell 
et al. 2011), and there is an expectation that PCPs will be able to answer questions about 
personal genome test results (McGuire et al. 2009). In the 2008 DocStyles survey, over 40% of 
PCPs aware of personal genome testing offered directly to the consumer reported they had 
patients ask them questions, and 15% reported that patients had actually brought in test results 
(Kolor et al. 2009). A similar study of PCPs in North Carolina found that almost 19% of PCPs 
aware of personal genome testing had a patient ask questions, and of those individuals, 
approximately 3% had a patient bring in their test results (Powell et al. 2011). This suggests that 
PCPs may see an increase in questions about personal genome test results should this type of 
testing become more mainstream. 
PCP’s generalized lack of knowledge about genetics and the fact that they do not feel prepared to 
answer patient questions about genetic topics, including personal genome tests has been 
documented (Greendale and Pyeritz 2001; Powell et al. 2011; Suther and Goodson 2003). In 
part, this could be the result of the dearth of formal genetics training in medical school and 
residency programs (Thurston et al. 2007). Few medical schools are exposing their students to 
information about GWAS and the role that SNP testing plays in the identification of risk factors 
to genetic disease (Vence 2010). 
Calls to increase genetics and genomics education in medical school and residency programs 
have been made (Guttmacher et al. 2007; Scheuner et al. 2008; Thurston et al. 2007; 
Vence 2010) and guidelines and initiatives to do this have been created (American Academy of 
Family Physicians Core Educational Guidelines: Medical Genetics 2011; Burke et al. 2002; 
Reigert-Johnson et al. 2004; Report VI - Contemporary Issues in Medicine: Genetics 
Education 2005). However, it has been demonstrated that medical students do not to retain 
genetics knowledge over the course of their medical school career (Baars et al. 2005; Greb et 
al. 2009; Ling et al. 2008; Swanson et al. 1996). Retention of knowledge regarding genetics may 
be further eroded by the fact that PCPs are more likely to see patients with common conditions 
such as heart disease or diabetes than those who have single gene disorders (Feero 2005). The 
speed at which the science is changing and new tests are developed also makes it difficult for 
PCPs to stay current in genetics. 
Several studies have evaluated education programs aimed at improving health care provider’s 
genetic knowledge (Bethea et al. 2008; Burke et al. 2002; Burke and Emery 2002; Laberge et 
al. 2009). However, these studies looked at genetics education in primary care (Burke et 
al. 2002; Guttmacher et al. 2001, 2007; Suther and Goodson 2003), and not at personal genome 
testing. At this time, information is scarce about how personal genome testing offered directly to 
consumers is relevant to PCP practice, if PCPs want to learn about these tests, and what supports 
are needed when questions arise. 
Purpose of the Present Study 
A goal of this study was to assess the education needs of North Carolina PCPs about DTC 
genetic testing. Other aims were to ascertain 1) PCPs’ preference for delivery of educational 
materials, 2) barriers to PCPs’ participation in a continuing education program and 3) PCPs’ 
preference for topics to include in an educational program on DTC genetic testing. 
Methods 
Participants 
A convenience sample of family physicians and internists who were members of the North 
Carolina Medical Society (NCMS) were recruited to participate (Powell et al. 2011). The NCMS 
is the state’s largest physician organization with more than 12,000 members (North Carolina 
Medical Society 2011). 
Survey Development 
A novel survey consisting of 30 questions was created to meet the goal of this project. A 
description of personal genome testing was adapted from the 2008 DocStyles survey developed 
by the Centers for Disease Control and Prevention (CDC), and provided in the introduction. It 
read: “Genetic tests that scan a person’s entire genetic makeup for potential health risks are 
currently being marketed directly to consumers by several different companies (e.g., 23andMe, 
deCODEme, Navigenics).” Respondents were told that the term ‘DTC genetic test’ would be 
used as a shorthand way to describe this service. 
Four of the 30 questions asked how PCPs would want to be educated about DTC genetic testing 
(Appendix A). The remainder of the questions asked about awareness, experience, opinions, 
preparedness to answer questions about DTC genetic testing and demographics (Powell et 
al. 2011). The survey was piloted with 10 family medicine and internal medicine physicians 
practicing in Greensboro, North Carolina. No modifications were made. This study was 
approved by The University of North Carolina at Greensboro’s Institutional Review Board. 
Procedures 
The physicians and surveys were numbered and a unique ID was created. Cover letters, surveys, 
informed consent, and a self-addressed stamped envelope (SASE) were mailed to all physicians 
with confirmed addresses (Powell et al. 2011). While no compensation was provided to 
respondents, they were offered a copy of the results once the survey was completed (Dillman et 
al. 2009; Lydeard 1996). Physicians completing the survey online were asked to enter their 
survey number to avoid duplication. When a survey was returned, the physician’s name and 
address were deleted from the key. Two reminders were sent to non-responders at three-week 
intervals. The first reminder was a postcard which referenced the online link. The second 
reminder contained a cover letter, survey and SASE. Data collection occurred between January 
and May, 2010. 
Statistical Analysis 
Information from the returned surveys was entered into Zoomerang, an on-line survey collection 
tool. Data analysis was conducted using PASW Statistics version 18.0 (Chicago, IL). The 
respondents’ personal characteristics and survey characteristics relating to self-reported 
preparedness to answer questions, desire to learn more, and how they want to learn about DTC 
genetic testing were described with frequencies and percent’s. The ages of participants were 
collected within five categories: ≤30, 31-40, 41-50, 51-60, and >60. The age variable was 
collapsed into two categories based on the participant’s experience. The variables ≤30 and 31-40 
were collapsed to ≤40 (less experienced PCPs), the variables 41-50, 51-60 and >60 were 
collapsed to ≥41 (more experienced). Board specialty was dichotomized into family medicine 
and internal medicine and work setting was dichotomized into private practice and other. 
Responses to the dependent variable (‘Would you like to learn more about DTC genetic 
testing?’) were categorized yes and no. 
All bivariate associations between physicians’ personal and survey characteristic variables and 
participant’s interest in education about DTC genetic testing were calculated using cross-
tabulations. Odds ratios and confidence intervals (CI) at 95% were calculated using standard 
procedures to assess determinants of interest in education about DTC genetic testing. For the 
outcome variable, the initial model was formulated by including all of the covariates provided in 
Tables 1 and 2. In order to reduce the initial model to the final reduced model, odds ratio (OR) 
estimates were used for all personal characteristics that were shown to be predictors of 
participants’ interest in education about DTC genetic testing. Covariates that were not 
statistically significant predictors of interest in education were eliminated from the full model 
using a step-wise forward regression procedure. Based on a previous analysis, age and years in 
practice were found to be significantly correlated (Pearson r = 0.721, p = 0.00), therefore years in 
practice was eliminated from the model. The aim of this methodology is to identify the strongest 
simplified model of respondents’ personal characteristics associated with the participant’s 
interest in education about DTC genetic testing. Multivariate adjusted ORs and their 95% 
confidence interval (CI) were determined by exploring log ORs from the multivariate logistic 
regression using a forward stepwise likelihood ratio model. Missing data were excluded from the 
analyses where appropriate. 
Table 1 Personal characteristics of respondents (N = 382)a 
Personal characteristics Total 
N (378) % 
Gender 
Female 115 30.4 
Male 263 69.6 
Age 
≤40 years old 153 40.9 
>40 years old 221 59.1 
Board specialtyb 
Family medicine 214 56.8 
Internal medicine 153 40.5 
Other 10 2.7 
Work setting 
Academic medical center or medical school 34 9.0 
Medical center not affiliated with university 9 2.4 
Community hospital 23 6.1 
Private practice 272 72.0 
HMO 0 0 
Other 40 10.6 
aTotals do not sum to the sample size due to missing data bTotals include double boarded 
specialty 
Table 2 Awareness of PCPs (N = 382), perceived utility and preparedness about DTC genetic 
testing among those aware of testing 
Self-reported Awareness of PCPs N % 
Heard or read about DTC genetic testing 
Yes 148 38.7 
No 234 61.3 
Clinical utility DTC genetic testing among those who are aware 
 Feel that DTC testing is clinically useful 
Yes 63 42.6 
No 85 57.4 
 Rating of clinical usefulness of DTC genetic testing a,b 
Very useful 3 5.1 
Useful 4 6.8 
Somewhat useful 50 84.7 
Not useful 2 3.4 
PCPs rating on likelihood that DTC test results would influence patient care b 
Very likely 7 4.8 
Likely 50 34.0 
Unlikely 70 47.6 
Very unlikely 20 13.6 
Preparedness about DTC genetic testingb 
 PCP preparedness about genetic testing 
Yes 57 15.0 
No 323 85.0 
aFrequency is based on the number of PCPs who feel that DTC testing is useful; bTotals do not 
sum to the sample size due to missing data 
Results 
Survey Characteristics 
As per the eligibility criteria, surveys were sent to 2,402 PCPs in North Carolina. Fifty surveys 
were ‘returned to sender’, resulting in 2,352 eligible respondents. In total, 397 surveys were 
returned to the researchers. Surveys were excluded from the final analysis if they were returned 
blank (n = 10) or the PCP was retired (n = 5), resulting in 382 completed surveys. The response 
rate for usable surveys in this study was 16.2% (382/2,352). 
Respondents had the option of returning the survey by mail, fax, or completing it on-line. Of the 
surveys completed, 95.3% were returned by mail (n = 364) and 4.7% were completed on-line 
(n = 18). No respondents returned the survey by fax. Respondent demographics are in Table 1. A 
total of 382 respondents who completed and returned the survey were included in the final 
analysis. A post-hoc analysis was conducted to determine the statistical power given the sample 
size of 382 which was 0.80. 
Sample Demographics 
Males accounted for two thirds of the respondent pool (69.6%, n = 263). More than half were 
>40 years old (59.1%, n = 221). Similarly, more than half of the respondents (56.8%, n = 214) 
were boarded in family medicine. Most of the respondents (72%, n = 272) worked in a private 
practice setting with an average of 21.8 (SD = 11.7) years in practice as a physician. 
Awareness, Experience and Opinions of DTC Genetic Testing 
As described previously, most respondents (61.3% n = 234) had never heard or read about DTC 
genetic testing (Table 2). Of those who were aware of DTC genetic testing (38.7%, n = 148), 
18.9% (n = 28) had patients ask questions about DTC testing (mean = 3 patients) and 3% (n = 5) 
had patients bring in DTC test results (mean = 2 patients). Four of the five providers indicated 
that they did not change patient care because there were no medical guidelines to follow or the 
test indicated that the patient was not at increased risk. One provider recommended lifestyle 
changes such as dietary changes and supplements (Powell et al. 2011). None of the providers 
indicated they referred a patient to a specialist based on their test results. 
Among aware respondents (n = 148), almost half (42.6%, n = 63) thought that testing was 
clinically useful when formulating medical management plans. The most frequently mentioned 
benefits were the ability to: 1) offer screening tests (e.g. mammograms, colonoscopies, EKG) at 
an earlier age to individuals at an increased risk and, 2) offer these screening tests more 
frequently to individuals who are found to be at an increased risk (Powell et al. 2011). A majority 
of the respondents (85%, n = 323) did not feel prepared to answer their patient’s questions 
regarding DTC genetic testing. In determining educational preferences of PCPs, bivariate 
associations were significant for PCPs who perceived clinical usefulness of DTC genetic testing. 
PCPs who were less prepared to answer questions about DTC genetic testing were also more 
likely to want to learn more about DTC genetic testing (Table 3). A multivariate logistic 
regression using a stepwise forward likelihood ratio indicated that PCPs perceived clinical 
usefulness of DTC genetic testing [OR = 5.783 (2.261, 14.789), p = .00] and PCPs preparedness 
to answer questions about DTC genetic testing [OR = 0.354 (0.149, 0.839), p = .01] were 
significant predictors of PCPs desire to learn more about DTC genetic testing. In order to further 
explore the interactions and impact of these two significant predictors on PCP’s desire to learn 
more, bivariate analyses were conducted. No significant associations were found between PCP’s 
perceived clinical usefulness and preparedness to answer questions about DTC testing (i.e. there 
was no significant overlap). 
Table 3 Bivariate analysis – determinants of education of PCPs about DTC genetic testing 
Participant characteristics DBP odds ratio (95% CI) 
Gender 
Female (reference) -- 
Male 0.869 (0.519, 1.453) 
Age 
≤40 years old (reference) -- 
>40 years old 0.954 (0.591, 1.540) 
Board specialty 
Family Medicine (reference) -- 
Internal Medicine 0.945 (0.590, 1.514) 
Awareness of DTC genetic testing 
No (reference) -- 
Yes 0.797 (0.496, 1.280) 
Perceived clinical usefulness of DTC genetic testing 
No (reference) -- 
Yes 5.783* (2.261, 14.789) 
Preparedness to answer questions about DTC genetic testing 
No (reference) -- 
Yes 0.354* (0.149, 0.839) 
*Significant at p < 0.05 
Desire to Learn About DTC Genetic Testing 
Approximately three fourths of the participants (73.8%, n = 282) reported that they wanted to 
learn more about DTC genetic testing (Table 4). The most common reasons PCPs did not want to 
learn more about DTC genetic testing included: (1) They would learn more if DTC genetic 
testing came up during a patient’s visit, (2) They did not think that their patients would ask about 
DTC genetic testing and (3) They do not believe that DTC genetic testing will have a significant 
impact on the provision of health care in the next 10 years/before they retire. The top three topics 
individuals reported wanting to learn more were: (1) interpreting the results; (2) evidence-based 
guidelines to manage risks identified by the DTC genetic test results; and, (3) the various DTC 
genetic tests offered by the private companies. Twenty five ‘Other’ responses were written in 
and could be placed into the following categories: Discrimination/privacy issues (n = 5), quality 
assurance (n = 5), cost of testing (n = 5), general comments (n = 5), legislation (n = 3), testing of 
minors (n = 1), and availability of non-vendor counseling (n = 1). Furthermore, journals 
(68.4%, n = 193), information sessions at professional meetings (62.0%, n = 175), and trusted 
internet websites (42.1%, n = 119) were cited as the three most common media through which 
PCPs wanted to learn more about DTC tests (Table 4). ‘Other’ responses included: uptodate.com 
(n = 2), podcasts (n = 1), dinner meetings/programs (n = 1), weekly conferences with course 
objectives (n = 1) and non-vendor based brochures (n = 1). Bivariate associations between PCP’s 
preparedness and top three areas for educational preferences were not statistically significant. 
There were no differences in educational preferences between the PCPs who had patients bring 
in test results and those who did not. 
Table 4 Bivariate analysis – determinants of education of PCPs about DTC genetic testing 
Participant characteristics DBP odds ratio (95% CI) 
Gender 
Female (reference) -- 
Male 0.869 (0.519, 1.453) 
Age 
≤40 years old (reference) -- 
>40 years old 0.954 (0.591, 1.540) 
Board specialty 
Family Medicine (reference) -- 
Internal Medicine 0.945 (0.590, 1.514) 
Awareness of DTC genetic testing 
No (reference) -- 
Yes 0.797 (0.496, 1.280) 
Perceived clinical usefulness of DTC genetic testing 
No (reference) -- 
Yes 5.783* (2.261, 14.789) 
Preparedness to answer questions about DTC genetic testing 
No (reference) -- 
Yes 0.354* (0.149, 0.839) 
*Significant at p < 0.05 
Discussion 
This study is among the first to look at the educational needs of PCPs whose patients ask 
questions about, or bring in test results from, personal genome DTC genetic testing. It highlights 
the lack of preparedness on the part of PCPs to answer questions about DTC genetic testing and 
their interest in learning more about this topic. 
This study found that 38.7% of providers were aware of DTC genetic testing. Previous studies 
have found similar awareness rates among PCPs about DTC genetic testing (Kolor et al. 2009). 
Lower awareness rates of DTC genetic testing, in part, could be a result of a low demand for 
DTC genetic testing in North Carolina, which has a relatively low median household income 
(41st in the nation) (2009 by the numbers 2009; US Census Bureau 2009; Pollack 2010; Wright 
and Gregory-Jones 2010). 
DTC genetic testing topics that PCPs want to learn more about, as well as the barriers to learning 
more, are similar to the educational needs and barriers for general genetics. This study found that 
barriers to learning more about DTC genetic testing included a perceived lack of clinical utility 
and the belief that test results would have little to no impact to primary care practice. These 
issues are also barriers to the utilization of general genetics within primary care (Hayflick et 
al. 1998; Mountcastle-Shah and Holtzman 2000; Suther and Goodson 2003). Some topics 
respondents wanted to learn more about pertaining to DTC genetic testing were unique to this 
type of service. However, several similarities were found between what respondents wanted to 
learn about in regards to DTC genetic testing and general genetics. These include: guidelines for 
managing risk (de Bock et al. 1999), costs of testing (Friedman et al. 1997; Mountcastle-Shah 
and Holtzman 2000) and ethical and legal issues including insurance discrimination (Friedman et 
al. 1997; Watson et al. 1999). 
Primary care physicians who feel that DTC genetic testing is clinically useful and those who do 
not feel prepared to answer patient questions are particularly interested in learning more about 
DTC genetic testing. According to the results of a previous study, family practice physicians 
were more likely than internal medicine physicians to find DTC personal genome testing 
clinically useful (Powell et al. 2011). Therefore, educational efforts could start by focusing on 
family practice physicians. 
Educational programs could address the top priorities identified by PCPs, as well as whether 
clinical intervention based on DTC testing results is appropriate, and the benefits of referring 
patients for genetic counseling. Almost half of the providers who were aware of DTC genetic 
testing felt that the testing had clinical utility; however, clinical utility of DTC genetic testing 
varies based on the test and its analysis (US Government Accountability Office (2010). 
Therefore an education program should address how clinical utility is assessed and what 
evidence determines whether a test would be beneficial or change medical management (Field et 
al. 2010). Lastly, five providers had an average of two patients each bring in test results (Powell 
et al. 2011); however, none of them referred their patients to genetics, genetic counseling or 
another specialist. Therefore, the educational program could address what a referral to a genetic 
counselor could provide for their patient. 
When planning an educational program, care should be taken to use the education channels that 
primary care providers routinely use (Burke and Emery 2002). According to this study, efforts 
that will have the largest impact include writing articles for journals commonly read by PCPs 
and working with regional and national physician organizations to include presentations about 
DTC personal genome testing at their annual education conferences. These educational 
initiatives should give providers information about DTC personal genome testing, including the 
pros and cons of testing, and the tools they will need to help patients make informed decisions 
about this testing. PCPs need information on how to interpret test results and the legislation that 
protects against discrimination. They also need a list of the specific evidence-based guidelines 
they can follow to reduce disease risk. 
This study suggests that PCPs are just-in-time learners who are driven by their need for 
information at a specific point in time. Therefore, educational initiatives should also include 
creating content about DTC personal genome testing on trusted websites that are used by primary 
care physicians. One such website mentioned in this study is uptodate.com (www.uptodate.com). 
The results of this study identify potential roles for genetic counselors in the DTC genetic testing 
arena. Genetic counselors have a diverse skill set that lends itself to providing education about 
DTC genetic testing to primary care providers. In addition to providing genetic counseling to 
patients who have undergone DTC genetic testing, genetic counselors could educate primary 
care providers through the channels they want to be educated. The National Society of Genetic 
Counselors 2010 Professional Status Report indicates a majority of respondents have created 
educational materials (62%), created or organized a conference or workshop for healthcare 
professionals (23%), written an article in either peer-reviewed journal (20%) or newsletter 
(11%), or developed a brochure/pamphlet/video (17%) (National Society of Genetic Counselors 
2010). These experiences mirror the desired education that providers indicated they wanted for 
DTC genetic testing. 
Limitations 
Several aspects of this study may have limited generalizability of the findings because of the fact 
that this is a convenience sample of PCPs, and there was a low response rate (16.2%). However, 
this was not unexpected. The literature indicates that surveys of general practitioners generally 
achieve poor response rates (McAvoy and Kaner 1996). Possible reasons for the low response 
rate include 1) lack of monetary incentives, 2) the mailed survey was four pages, printed front 
and back and appeared long, and/or 3) the topic was not of current clinical interest to the PCP 
population. Also, it cannot be determined how representative they survey respondents are of the 
general PCP population in North Carolina given that the only demographic charcteristic we 
could compare was gender. The gender demographics of this survey resembles the gender 
distribution of the NCMS membership (i.e. 66% and 73% males in family practice and internal 
medicine, respectively); these are the only demographic characteristics we could compare as the 
NCMS did not respond to requests for information concerning other demographic characteristics 
of their members. Additionally, the places North Carolina PCPs turn for information are similar 
to the results reported in other studies (Hofman et al. 1993; Kolor et al. 2009; Ohata et al. 2009). 
A second limitation of this study is that adults are just-in-time learners who are often driven by 
their need for information at a specific point in time. Therefore, we cannot determine if interest 
in this topic was generated by the survey itself, or if it represents a true interest of PCPs in 
learning more about personal genomic testing and its impact on their practice. Future studies 
could ask providers to rank topics related to DTC genetic testing relative to other topic areas 
outside of genetics and genomics (i.e. chronic disease management) in order to get an idea of 
their educational priorities. 
A final limitation to the generalizability of this study is that patient demographics vary between 
states. The background of the typical patient in North Carolina may differ from those in other 
states within the region or throughout the US. Therefore, the experience of PCP’s in North 
Carolina as they relate to DTC genetic testing may vary from the experiences of PCP’s in other 
states. Nevertheless, this study does provide preliminary findings for a larger comprehensive 
study. 
Research Recommendations 
This study focused solely on physicians. Other health care professionals, such as physician 
assistants and nurse practitioners who specialize in primary care, will also need to be queried 
about their educational needs surrounding DTC testing. These providers may have educational 
needs that are distinctly different from those of the physicians. 
Conclusions 
Primary care providers are interested in learning about DTC genetic testing. Topics of particular 
interest include interpreting test results, evidence-based guidelines to manage risks and 
information about the various DTC genetic tests. An educational initiative to improve knowledge 
about DTC genetic tests and address concerns about genetic discrimination may be most 
effective if it targets family practice physicians and uses familiar and trusted channels such as the 
publication of articles in journals read by PCPs, presentations at their regional and national 
meetings, and the development of web-based materials published on a trusted site. With their 
education, training and skills, genetic counselors are well poised to help develop, conduct and 
evaluate the educational efforts about DTC genetic testing for PCPs as well as all health care 
professionals. The goal is to give providers the information and tools they need to help patients 
make informed decisions about DTC genetic testing and to help them interpret their patients’ test 
results and what they mean for medical management. 
Appendix A: Questions Asking PCPs How They Want to be Educated About DTC Genetic 
Testing 
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